Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
about
Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.Mitochondrial dysfunction in cardiac agingAltered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart.Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycinMitochondrial approaches to protect against cardiac ischemia and reperfusion injury.KLF15 and PPARα Cooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation.Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle.Kruppel-like factors in muscle health and disease.Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function.Mesenchymal stem cell transplantation for the infarcted heart: a role in minimizing abnormalities in cardiac-specific energy metabolism.GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle.In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceAdrenergic receptors and metabolism: role in development of cardiovascular diseaseKruppel-like factor 15 is a critical regulator of cardiac lipid metabolismRearrangement of energetic and substrate utilization networks compensate for chronic myocardial creatine kinase deficiency.Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin.The Effect of a High-Protein Diet and Exercise on Cardiac AQP7 and GLUT4 Gene Expression.A new strategy to decrease cardiac injury in aged heart following ischemia-reperfusion: Enhancement of the interaction between AMPK and SIRT1.
P2860
Q26853332-CBB82BA5-13B2-4B94-9B58-7B66F6CF4DA4Q28389063-58C80040-950F-4D49-88E0-5AE9E7249CCAQ33692414-937079E5-3825-4D35-A9D2-70ADC5A45E20Q33719493-4E4ACC0D-3B83-4414-A109-69C79CF5D824Q34854255-8E222A21-9B55-4C2E-BAC1-D732BA8649E6Q35169996-669FFF57-B4D6-4F37-AE89-6FCFE93BA582Q35312286-BB9A0DCF-8FA5-410E-8D72-22639F7828F7Q35575864-69815D90-B645-492E-9455-58DADCCE5E2FQ35862403-B9B07B8B-5B4C-4684-9758-0A249761A76AQ35924405-DC26B06D-5057-443C-8AAE-21540AC81F50Q36156657-90AD85D8-D80E-4EF6-96F0-2B2FB59CECB5Q36364300-29345F2C-7B56-4FC8-BFD6-C93D3133C19EQ37212200-663CEF32-335C-4A01-89A1-0A0762FD796CQ37608509-D665A479-C976-422E-A49E-92A81247444FQ39289613-60899345-A813-4424-BDAF-9A42A199B2DBQ41824788-BBE6531E-561B-4CCF-9D95-F45C56DC62ECQ48042168-67C7B163-0FA1-4AC5-8EA0-4E7115B05532Q52621938-41391A96-F624-44F9-8E8D-3FFB0ECEB116
P2860
Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
@en
Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
@nl
type
label
Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
@en
Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
@nl
prefLabel
Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
@en
Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
@nl
P2860
P1476
Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
@en
P2093
Stephen C Kolwicz
P2860
P304
P356
10.1016/J.TCM.2009.12.005
P50
P577
2009-08-01T00:00:00Z